腹腔残余癌与腹穿化疗──中晚期卵巢癌的治疗

Abdominal chemotherapy of abdominal residual carcinoma-The treatmtment of moderate or advanced ovarian carcinoma

本文报告了２８例中晚期卵巢癌患者采用腹腔＋静脉化疗，消除缩瘤术后腹腔残余癌，延长生存时间，收效甚好。腹腔化疗采用单点穿刺，均获一次成功。注入溶解的ＤＤＰ液５０—１５０ｍｌ，内含药物４０—８０ｍｇ，未出现并发症。残余癌经Ｂ超检查或二探手术证实明显缩小或消失。原发性卵巢癌较转移性卵巢癌治疗效果好。

It is reported that 28 patients with moderate or advanced ovarian carcinoma were treated with abdominal chemotherapy and intravenous chemotherapy. This method is better for eliminenting the residual carcinoma and prolonging survival time. Abdominal chemotherapy was first succesed by a single puncture. 50-150 ml liquid containing 40-80 mg DDp was injected into the abdominal cavity and no complications appeared. It was confirmed that residual carcinornas were reduced or extinguished by B-us or second-laparotomy. This therapy is better to primary ovarisn carcinoma than metastatis carcinoma.